Biocon board approves sale of branded formulations business to subsidiary
The company has fixed July 1, 2019, as the expected date of completion of the sale
Author
Pfizer to buy Array Biopharma for $10.64 bn in cash
Array is Pfizer’s first major purchase under new Chief Executive Albert Bourla, who took on the role in January
Pfizer will buy…
ConcePTION awarded grant to conduct research on meds used for pre- and post-natal care
The project unites 88 organisations from 22 countries, including the European Medicines Agency, drug manufacturers, academia,…
Laurus Labs finishes USFDA inspection of its API facilities in Visakhapatnam
“This was a regular surveillance audit by US FDA, and no data integrity issues were observed in the inspection,” the company…
Brinton Pharmaceuticals receives Series B funding from India Alternatives
Brinton is focused on dermatology and has recently expanded into the paediatric dermatology & respiratory segments
Brinton…
Lupin recalls over 18,000 bottles of antibiotic drug in US
The company is recalling the drug, Cefdinir, due to “complaint received of metal piece identified in the product bottle prior to…
Novartis India appoints Sanjay Murdeshwar as Vice Chairman and Managing Director
Murdeshwar will take over as Country President, Novartis India, to lead its pharma business, and as Managing Director of Novartis…
AstraZeneca’s drug showed reduced Chronic Kidney Disease progress in cases of type-2 diabetes
Forxiga, the drug, showed a 47 per cent reduction in the composite of kidney function decline, end-stage renal disease or renal…
US FDA makes 2 observations for Caplin’s sterile injectable site in Chennai
Caplin Point Laboratories said it believes these observations are procedural in nature and corrective and "preventive actions for…
25 batches of drugs of 18 pharma companies found substandard since January 2018 by BPPI
While 17 out of the 18 companies are private, one is a public sector unit (PSU) - Indian Drugs and Pharmaceuticals Limited (IDPL)